Loxo Oncology (LOXO) PT Lowered to $108 at Citi on Bayer Collaboration for Laro & LOXO-195; 'Deal Not Exactly What We Expected, But Still Very Good'
Tweet Send to a Friend
Citi lowered its price target on Loxo Oncology (NASDAQ: LOXO) to $108.00 (from $112.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
